FDA Requiring Suicide Risk Assessment for Clinical Trials
Feb 9, 08 According to a recent New York Times article, the FDA is now requiring drug makers to assess suicide risk during clinical trials.
Critics say this requirement is long overdue, while others say determining depressive versus suicidal effects is too difficult to establish.
Do you agree or disagree with the FDA's requirement? Comments?
Feb 9, 08 According to a recent New York Times article, the FDA is now requiring drug makers to assess suicide risk during clinical trials.
Critics say this requirement is long overdue, while others say determining depressive versus suicidal effects is too difficult to establish.
Do you agree or disagree with the FDA's requirement? Comments?